Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once‐weekly, human GLP‐1 analogue, after single‐dose administration in patients with Type 2 diabetes
Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetic Medicine
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Ipsen
OpenAlex ID: W1984737165
